KN3 Vaccine Manufacturing in Africa: Self-sufficiency, a need? Or a dream?

Sign-in

User Name

Password

Remember Me

Forgot your password?
Forgot your username?

Create an account

Home
About
Mission
Partners
History
Contact
Privacy
Terms
Community
Dashboard
Forum
Groups
Events
Careers
Blogs
Knowledge Hub
Vaccines & devices

Supply chain

Service delivery

Data

Programme management

Global initiatives
Conference
2020
2017
2015
More
Countries

Africa

Algeria

Angola

Benin

Botswana

Burkina Faso

Burundi

Cabo Verde

Cameroon

Central African Republic

Chad

Comoros

Congo

Cote D Ivoire

Democratic Republic Of The Congo

Equatorial Guinea

Eritrea

Eswatini

Ethiopia

Gabon

Gambia

Ghana

Guinea

Guinea Bissau

Kenya

Lesotho

Liberia

Madagascar

Malawi

Mali

Mauritania

Mauritius

Mayotte

Mozambique

Namibia

Niger

Nigeria

Reunion

Rwanda

Sao Tome And Principe

Senegal

Seychelles

Sierra Leone

South Africa

South Sudan

Swaziland

Togo

Uganda

United Republic Of Tanzania

Zambia

Zimbabwe

Algeria
Angola
Benin
Botswana
Burundi
Cabo Verde
Cameroon
Central African Republic
Chad
Comoros
Congo (Brazzaville)
Congo (Kinshasa)
Cote D`Ivoire
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Mauritius
Mozambique
Namibia
Niger
Nigeria
Rwanda
Sao Tome And Principe
Senegal
Seychelles
Sierra Leone
South Africa
Swaziland
Tanzania
Togo
Uganda
Zambia
Zimbabwe
Burkina Faso

Americas

Anguilla

Antigua And Barbuda

Argentina

Aruba

Barbados

Belize

Bermuda

Bolivia Plurinational State Of

Brazil

British Virgin Islands

Canada

Cayman Islands

Chile

Colombia

Costa Rica

Cuba

Dominica

Dominican Republic

Ecuador

El Salvador

Falkland Islands Malvinas

French Guiana

Grenada

Guadeloupe

Guatemala

Guyana

Haiti

Honduras

Jamaica

Martinique

Mexico

Montserrat

Netherlands Antilles

Nicaragua

Panama

Paraguay

Peru

Puerto Rico

Saint Helena

Saint Kitts And Nevis

Saint Lucia

Saint Pierre And Miquelon

Saint Vincent And The Grenadines

St Eustatius

Suriname

The Bahamas

Trinidad And Tobago

Turks And Caicos Islands

United States

United States Virgin Islands

Uruguay

Venezuela Bolivarian Republic Of

Antigua And Barbuda
Argentina
Barbados
Belize
Bolivia
Brazil
Canada
Chile
Colombia
Costa Rica
Cuba
Dominica
Dominican Republic
Ecuador
El Salvador
Grenada
Guatemala
Guyana
Haiti
Honduras
Jamaica
Mexico
Nicaragua
Panama
Paraguay
Peru
Saint Kitts And Nevis
Saint Lucia
Saint Vincent And The Grenadines
Suriname
The Bahamas
Trinidad And Tobago
United States
Uruguay
Venezuela

South-East Asia

Bangladesh

Bhutan

India

Indonesia

Korea North

Maldives

Myanmar

Nepal

Sri Lanka

Thailand

Timor Leste

Bangladesh
Bhutan
India
Indonesia
Korea North
Maldives
Myanmar
Nepal
Sri Lanka
Thailand
Timor-Leste

Europe

Albania

Andorra

Armenia

Austria

Azerbaijan

Belarus

Belgium

Bosnia And Herzegovina

Bulgaria

Croatia

Cyprus

Czech Republic

Denmark

Estonia

Faroe Islands

Finland

France

Georgia

Germany

Gibraltar

Greece

Greenland

Hungary

Iceland

Ireland

Isle Of Man

Israel

Italy

Kazakhstan

Kyrgyzstan

Latvia

Liechtenstein

Lithuania

Luxembourg

Malta

Monaco

Montenegro

Netherlands

Norway

Poland

Portugal

Republic Of Moldova

Romania

Russian Federation

San Marino

Serbia

Slovakia

Slovenia

Spain

Svalbard And Jan Mayen Islands

Sweden

Switzerland

Tajikistan

The Former Yugoslav Republic Of Macedonia

Turkey

Turkmenistan

Ukraine

United Kingdom Of Great Britain And Northern Ireland

Uzbekistan

Albania
Andorra
Armenia
Austria
Azerbaijan
Belarus
Belgium
Bosnia And Herzegovina
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Georgia
Germany
Greece
Hungary
Iceland
Ireland
Israel
Italy
Kazakhstan
Kyrgyzstan
Latvia
Lithuania
Luxembourg
Malta
Monaco
Montenegro
Netherlands
Norway
Poland
Portugal
Republic of Moldova
Romania
Russia
San Marino
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Tajikistan
The Former Yugoslav Republic Of Macedonia
Turkey
Turkmenistan
Ukraine
United Kingdom
Uzbekistan

Eastern Mediterranean

Afghanistan

Bahrain

Djibouti

Egypt

Iran Islamic Republic Of

Iraq

Jordan

Kuwait

Lebanon

Libya

Morocco

Oman

Pakistan

Qatar

Saudi Arabia

Somalia

State of Palestine

Sudan

Syrian Arab Republic

Tunisia

United Arab Emirates

West Bank And Gaza Strip

Western Sahara

Yemen

Afghanistan
Bahrain
Djibouti
Egypt
Iran
Iraq
Jordan
Kuwait
Lebanon
Libya
Morocco
Oman
Pakistan
Qatar
Saudi Arabia
Somalia
South Sudan
Sudan
Syria
Tunisia
United Arab Emirates
Yemen

Western Pacific

American Samoa

Australia

Brunei Darussalam

Cambodia

China

Christmas Island

Cocos Keeling Islands

Cook Islands

Fiji

French Polynesia

Guam

Japan

Kiribati

Korea South

Lao People S Democratic Republic

Laos

Malaysia

Marshall Islands

Micronesia Federated States Of

Mongolia

Nauru

New Caledonia

New Zealand

Niue

Norfolk Island

Northern Mariana Islands

Palau

Palau

Papua New Guinea

Philippines

Pitcairn Island

Samoa

Singapore

Solomon Islands

Taiwan

Tokelau

Tonga

Tuvalu

Vanuatu

Viet Nam

Wallis And Futuna

American Samoa
Australia
Brunei
Cambodia
China
Cook Islands
Fiji
Japan
Kiribati
Korea South
Laos
Malaysia
Marshall Islands
Micronesia Federated States Of
Mongolia
New Zealand
Palau
Papua New Guinea
Philippines
Samoa
Singapore
Solomon Islands
Taiwan
Tonga
Tuvalu
Vanuatu
Vietnam
Diseases

Cholera

Covid-19

Dengue

Diphtheria

Ebola

Haemophilus influenzae

Hepatitis A

Hepatitis B

Hepatitis E

HIB

HIV-AIDS

Human papillomavirus

Influenza

Japanese encephalitis

Malaria

Measles

Meningococcal meningitis

Mumps

Pertussis

Pneumococcal disease

Polio

Rabies

Rotavirus

Rubella

Smallpox

Tetanus

Tick-borne encephalitis

Tuberculosis

Typhoid

Varicella

Yellow fever

Zika
Organisations

Bill & Melinda Gates Foundation

Gavi, the Vaccine Alliance

Global Vaccine Action Plan (GVAP)

Immunization Practices Advisory Committee (IPAC)

International Vaccine Access Center (IVAC)

JSI

MSF

PATH

People that Deliver (PtD)

Strategic Advisory Group of Experts on Immunization (SAGE)

TechNet-21

UNICEF

USAID

WHO

WHO Performance, Quality and Safety (PQS)
Hot Topics

Home-based records
Cold chain equipment
View all

The Knowledge Hub for immunization professionals

Browse thousands of immunization resources shared by TechNet members

Hot Topics
Forum
Cold chain equipment
Home-based records

Filter:

Start discussion

Related resources

KN1 Opening Session and Dr Margaret Chan Keynote

P1.1a RSA & HIV vaccine efficacy studies

P1.1b HIV Vaccines: Marry HIV efficacy studies to science, but take shots on goal

P1.2a TB Vaccine Research and Development: Progress, Strategies and Controversies

P1.3a Malaria Vaccines

P1.3b Vaccines for Malaria - Updates on Progress

P2 The role of moderate efficacy vaccines in integrated disease control strategies

P2.1 The role of moderate efficacy vaccines in integrated disease control strategies: Introduction

P2.2 Lessons from Rotavirus and Pneumococcal Conjugate Vaccines

P2.3 Moderate efficacy malaria vaccines as part of comprehensive malaria control and elimination

P2.4 Reflections on the use of future HIV vaccines as part of an integrated package of preventive measures

P3 Evolving Global Vaccine Markets

P3.1 Global vaccine market

P4 Preparing for the next Infectious Disease Emergency

P4.1 Preparing for the inevitable

P4.2 Preparing for the Next Infectious Disease Emergency

P4.3 Regulatory Preparedness for the Next Infectious Disease Emergency

P5 New Technologies to Support Measles Elimination

P5.1 What are the measles vaccination coverage gaps?

P5.2 The Investment Case for Measles Eradication

P5.3 Measles and Rubella Research Agenda

P5.4 An emerging vaccine delivery technology for measles and rubella elimination

P6.2 Vaccine development for Group A Streptococcus

P6.3 Schistosomiasis Vaccine Updates

P6.4 Preferred Product Characteristics

W2 Comprehensive assessment of risks and benefits of vaccines: the example of Dengue

W8 Combination Vaccines: Why and How?

W9 Gavi's Vaccine Investment Strategy (VIS)

W1.0 Introduction: Applying Novel Technologies to Vaccine Development

W1.1 Structural studies of viral envelope proteins and insights for vaccine design

W1.2 Epitope-focused vaccine design

W1.3 Design of self-assembling protein nanomaterials as next.generation vaccine scaffolds

W10.1 Monoclonal antibodies for infectious diseases

W10.2 Passive vaccination as a global strategy for preventing RSV disease in infants

W10.3 Gene-based Delivery of Broadly Neutralizing Antibodies for HIV Prevention

W10.4 Rabies antibodies for Passive Post-exposure prophylaxis

W11.1 Vaccine Hesitancy: what it means and what we need to know in order to tackle it

W11.2 Vaccine Hesitancy: Determining the scale of the challenge

W11.3 Tailoring Immunization Programmes (TIP): An example of tailoring communication on vaccinations targeting hard.to.serve communities in Sweden

W11.4 Applying TIP to low and middle income settings: a case study from South Africa

W2.2 Public Health Criteria for Dengue Vaccine Risk/Benefit Assessment and Risk Management

W3.1 Introduction: Total Systems Effectiveness

W3.2 Total System Effectiveness

W3.3 Microarray patch case study: Measles-rubella vaccine

W3.4 Vaccine technology costs and health impact assessment tool

W4.1 Introduction: Antimicrobial Resistance & Vaccines

W4.2 WHO Global Action Plan on Antimicrobial Resistance

W4.3 The Role of Vaccines in Antimicrobial Resistance Strategies

W4.4 Vaccines to prevent antibiotic-resistant Staphylococcus aureus (MRSA) infections

W4.5 Gonococcal antimicrobial resistance and vaccines

W4.6 Vaccines for healthcare pathogens: No ESKAPE

W5 Regulatory Challenges and Constraints When Evaluating Vaccine Clinical Trials

W5.1 WHO Regulatory Strengthening Update & LMICs Challenges in Vaccine Clinical Trial Regulation

W5.2 African Vaccine Regulatory Forum (AVAREF): New Vision and Blueprint for Ethics and Regulatory Capacity Strengthening in Africa

W5.3 Good Participatory Practices for Vaccine Clinical Trials

W6 Immunization in the Second Year of Life

W6.0 Intro: Establishing a Second-year-of-life (2YL) Healthy Child Visit

W6.1 Global landscape analysis and literature review of 2nd year of life immunization platform

W6.2 Raising the Profile of an 18-month Well-child Visit: the 2YL Platform

W6.3 Protecting Lives in the 2nd Year of Life (2YL) in Ghana

W6.4 Second year of life platform and monitoring systems

W7.1 The infant microbiome: Relevance to immune responses

W7.2 The Nasal Microbiota: Diversity, Dynamicity, and Vaccine-mediated Effects

W7.3 Intestinal Microbiota and Enteric Vaccine Design

W8.1 Combination Vaccines: How and Why? Lessons Learned

W8.2 Combination Vaccines: Potential future states

W8.3 Combination Vaccines: Benefits and Risks

W9.1 How does Gavi make vaccine investment decisions?

W9.2 What’s Next for Gavi's Vaccine Investment Strategy: Rabies

W9.3 Maternal influenza vaccines: How has the VIS process influenced the research agenda

*Meeting report: Global vaccine and immunization research forum

Context and Purpose of GVIRF

W3 Total Systems Effectiveness

W3 Total Systems Effectiveness

P6.1 Universal Influenza Vaccine Development

W11 Vaccine Hesitancy

KN3 Vaccine Manufacturing in Africa: Self-sufficiency, a need? Or a dream?

Keynote presentation

Author

Publication year

2016

Language

Type

Category

Global initiatives

Tags

Related reference code

Added by: Angela Hwang
Added on: 04 August, 2022
Hits: 98

Only logged in users are allowed to add feedback.

Edit resource

1 .Selecting a type
2 .Select a Category
3-
4-

Type *

Category *

Vaccines & delivery devices

Supply chain & logistics

Service delivery

Data

Programme management

Global initiatives

Title *

Description *

Author *

Language *

Country

Organisation

Thumbnail

Resource upload

Link

Publication year

Publisher

Related Resource Reference

Tags

30DTR

AEFI

Anti-vax

App

Barcode

BCG

BID

Biometrics

Campaign

CCEOP

Cloud

CMYP

Cold box / vaccine carrier

Cold room / freezer room

Disease

Cholera

Covid-19

Dengue

Diphtheria

Ebola

Haemophilus influenzae

Hepatitis A

Hepatitis B

Hepatitis E

HIB

HIV-AIDS

Human papillomavirus

Influenza

Japanese encephalitis

WHO Region

PubMed URL

Journal

Volume

Issue

Subnational area (if relevant)

Year of introduction (approximate)

Remit

Maternal health: Does the HBR include maternal health recording info?

Childhood vaccination information is recorded?

Childhood growth monitoring information is recorded?

Newborn health information is recorded?

CRVS-related information is recorded?

Other child survival information is recorded?

Child health information beyond first year is recorded?

Size

Format

Update resource

Resource updated successfully

You have successfully updated a resource

View resource

Back to library

Established by WHO and UNICEF in 1989, we are a global network of immunization professionals committed to strengthening immunization services

Home
About Us
Mission
Partners
History
Contact
Terms

Knowledge Hub
Vaccines & Devices
Supply chain
Service delivery
Data
Programme management
Global initiatives

Community
Dashboard
Forum
Events
Careers
Blogs

More
Countries
Diseases
Organisations
Hot Topics

© TechNet-21.org 2022. All right reserved.
Terms and Conditions
Privacy Policy
Sitemap
Disclaimer

Site Language: